[HTML][HTML] A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

…, VKM Poon, WM Chan, JD Ip, JP Cai, VCC Cheng… - The lancet, 2020 - thelancet.com
Background An ongoing outbreak of pneumonia associated with a novel coronavirus was
reported in Wuhan city, Hubei province, China. Affected patients were geographically linked …

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort …

…, ACK Ng, RWS Poon, CT Luo, VCC Cheng… - The Lancet infectious …, 2020 - thelancet.com
Background Coronavirus disease 2019 (COVID-19) causes severe community and nosocomial
outbreaks. Comprehensive data for serial respiratory viral load and serum antibody …

[HTML][HTML] Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

JSM Peiris, CM Chu, VCC Cheng, KS Chan, IFN Hung… - The lancet, 2003 - thelancet.com
Background We investigated the temporal progression of the clinical, radiological, and
virological changes in a community outbreak of severe acute respiratory syndrome (SARS). …

Consistent detection of 2019 novel coronavirus in saliva

…, AYF Fung, IFN Hung, VCC Cheng… - Clinical Infectious …, 2020 - academic.oup.com
The 2019 novel coronavirus (2019-nCoV) was detected in the self-collected saliva of 91.7%
(11/12) of patients. Serial saliva viral load monitoring generally showed a declining trend. …

[HTML][HTML] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label …

…, JFW Chan, AKW Lie, OTY Tsang, VCC Cheng… - The Lancet, 2020 - thelancet.com
Background Effective antiviral therapy is important for tackling the coronavirus disease 2019
(COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, …

Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)

…, V Lavergne, L Baden, VCC Cheng… - Clinical Infectious …, 2020 - academic.oup.com
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2

VCC Cheng, SC Wong, VWM Chuang, SYC So… - Journal of Infection, 2020 - Elsevier
Background Face mask usage by the healthy population in the community to reduce risk of
transmission of respiratory viruses remains controversial. We assessed the effect of …

Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated in …

…, GKY Choi, AR Tam, VCC Cheng… - Journal of clinical …, 2020 - Am Soc Microbiol
On 31 December 2019, the World Health Organization was informed of a cluster of cases of
pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a …

Neutralization of severe acute respiratory syndrome coronavirus 2 omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients

…, R Zhang, CCY Yip, VCC Cheng… - Clinical Infectious …, 2022 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron
variant, designated as a variant of concern by the World Health Organization, carries …

Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic

…, JFW Chan, AJX Zhang, VCC Cheng… - Emerging microbes & …, 2021 - Taylor & Francis
Without modern medical management and vaccines, the severity of the Coronavirus
Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) …